drugset / Trial / NCT00293670

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

NCT00293670

RandomizedParallel-groupOpen-labelTreatment

Summary

To compare intermittent androgen deprivation (LHRHa treatment) with continuous androgen deprivation (LHRHa treatment or orchidectomy)

Timeline

Start
1997-05
Primary completion
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified 3.6 mg

Indications

No indication recorded.